UnitedHealth Group Incorporated (NYSE:UNH) is Mitchell Mcleod Pugh & Williams Inc.’s 6th Largest Position

Mitchell Mcleod Pugh & Williams Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,138 shares of the healthcare conglomerate’s stock after selling 305 shares during the period. UnitedHealth Group comprises 1.6% of Mitchell Mcleod Pugh & Williams Inc.’s portfolio, making the stock its 6th largest position. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $2,065,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after buying an additional 1,122,534 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of UnitedHealth Group by 29.9% in the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after buying an additional 766,573 shares during the last quarter. Swiss National Bank increased its position in shares of UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after buying an additional 763,161 shares during the last quarter. Teachers Advisors LLC increased its position in shares of UnitedHealth Group by 56.8% in the fourth quarter. Teachers Advisors LLC now owns 1,929,490 shares of the healthcare conglomerate’s stock valued at $308,796,000 after buying an additional 698,955 shares during the last quarter. Finally, Karp Capital Management Corp acquired a new position in shares of UnitedHealth Group during the first quarter valued at approximately $113,729,000. 86.21% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 190.82 on Friday. The company has a market capitalization of $184.50 billion, a PE ratio of 22.92 and a beta of 0.64. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The firm’s 50 day moving average price is $190.49 and its 200-day moving average price is $175.87.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the company earned $1.96 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be given a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.57%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by BNB Daily and is the property of of BNB Daily. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/unitedhealth-group-incorporated-nyseunh-is-mitchell-mcleod-pugh-williams-inc-s-6th-largest-position-updated.html.

UNH has been the subject of several research analyst reports. Deutsche Bank AG reissued a “buy” rating and set a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Jefferies Group LLC reissued a “buy” rating and set a $192.00 target price (up previously from $186.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. UBS AG reissued a “buy” rating and set a $194.00 target price (up previously from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Cantor Fitzgerald reissued an “overweight” rating and set a $205.00 target price (up previously from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $187.00 target price (up previously from $186.00) on shares of UnitedHealth Group in a research note on Friday, April 21st. One research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $203.41.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the sale, the director now directly owns 75,735 shares in the company, valued at approximately $13,832,240.40. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,540 shares of company stock worth $2,873,320. Corporate insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply